Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stem cell-based therapies for retinal disorders].

U Bartsch1, S J Linke, B Petrowitz

  • 1Transplantationslabor des Kopf- und Hautzentrums, Klinik und Poliklinik für Augenheilkunde des Universitätsklinikums Hamburg-Eppendorf, Hamburg. ubartsch@uke.uni-hamburg.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|May 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking.

International ophthalmology·2025
Same author

[Uncommon treatment options for epithelial ingrowth after laser lenticule extraction].

Die Ophthalmologie·2023
Same author

[Successful refractive surgical treatment of a patient with keratoconus using phakic intraocular lenses].

Die Ophthalmologie·2021
Same author

[Neuronal ceroid lipofuscinoses].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Refractive surgical treatment of a keratoconus patient using combined excimer laser ablation and corneal cross-linking (Athens protocol)].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

Sleep problems and associations with psychopathology and cognition in young people with 22q11.2 deletion syndrome (22q11.2DS).

Psychological medicine·2019
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Stem cells offer promising therapeutic potential for retinal dystrophies. Research explores embryonic, mesenchymal, hematopoietic, neural, and retinal stem cells for cell replacement and ex vivo gene therapy strategies.

Area of Science:

  • Regenerative Medicine
  • Ophthalmology
  • Stem Cell Biology

Context:

  • Hereditary retinal dystrophies and other retinal disorders present significant challenges.
  • Cell-based therapies are emerging as a promising treatment avenue.
  • Stem cells possess unique properties for regenerative applications.

Purpose:

  • To review the therapeutic potential of various stem cell types for retinal disorders.
  • To discuss the application of stem cells in cell replacement and ex vivo gene therapy.
  • To evaluate experimental work on embryonic, mesenchymal, hematopoietic, neural, and retinal stem cells.

Summary:

  • Stem cells, characterized by self-renewal and multipotency, can be expanded in vitro and differentiated into specialized cell types.

Related Experiment Videos

  • These properties make stem cells suitable for cell replacement strategies in retinal diseases.
  • Stem cells are also valuable for developing ex vivo gene therapies for inherited retinal dystrophies.

    • Impact:

    • Highlights the potential of stem cell therapies for treating inherited retinal dystrophies.
    • Provides an overview of different stem cell types being investigated for retinal applications.
    • Informs future research directions in regenerative ophthalmology and gene therapy.